Commercialization

Navigate Complexities and Make Informed Choices That Unlock Breakthrough Value for Your Assets, Portfolios, and Organization

Navigate Commercialization Complexities With Confidence

Our commercialization strategy experts work across therapeutic areas and throughout the product life cycle to develop strategic, fit-for-purpose solutions at the asset, portfolio, and corporate levels. Recognized for our ability to guide high-stakes decisions, we de-risk development and accelerate commercial success. Our team of 200+ consultants, former industry leaders, scientists, and therapeutic area specialists brings innovative, multidimensional thinking to maximize your product’s value.

By evaluating opportunities and setting direction, we transform ideas into action. We ensure that your product stands out in the market, your portfolios are future ready, and your organization is equipped to execute, scale, and thrive.

Put our deep expertise, agility, and cross-functional collaboration to work for you.

Our Offerings

We ensure that your assets are aligned with business objectives and positioned effectively in the market to maximize impact. Through customized insight generation and strategic alternative evaluation, we help you shape your assets for future success with:

Early-stage business development

Opportunity identification and quantification

Early development feasibility assessment

Indication prioritization and sequencing

Target product profile development

Value proposition definition and early access strategy

Early commercial planning

We work with our clients to develop and implement powerful strategies and plans that deliver critical value to stakeholders and drive growth in challenging markets. Our experts provide data-driven insights and strategic guidance to support decision making at each stage of an asset’s journey, including:

Go-to-market strategy and implementation

Brand strategy, planning, and management

Launch excellence

Lifecycle management

Competitive strategy and scenario planning

Market access strategy

Forecasting, valuation, and commercialization modeling

We partner with you to build organizational structures, capabilities, and processes to translate plans into action and compete in today’s environment. Tap into our deep operational expertise, benchmarks, and industry knowledge for tailored strategies to achieve your vision. Our experts can advise on:

New commercial enterprise planning

Strategic function capability planning

Digital strategy

Governance models

We help our clients make strategic decisions that optimize asset and platform opportunities; mitigate risks; and drive innovation, differentiation, and value. Our asset life cycle experts can help you navigate strategic growth and expansion opportunities at a corporate level or within specific therapeutic areas. Our services include:

Organizational growth and transformation

Portfolio planning and management

Therapeutic area expansion planning

Business development and licensing opportunities

Global market expansion planning

Turnaround strategies

Early-stage business development

Opportunity identification and quantification

Early development feasibility assessment

Indication prioritization and sequencing

Target product profile development

Value proposition definition and early access strategy

Early commercial planning

Go-to-market strategy and implementation

Brand strategy, planning, and management

Launch excellence

Lifecycle management

Competitive strategy and scenario planning

Market access strategy

Forecasting, valuation, and commercialization modeling

New commercial enterprise planning

Strategic function capability planning

Digital strategy

Governance models

Organizational growth and transformation

Portfolio planning and management

Therapeutic area expansion planning

Business development and licensing opportunities

Global market expansion planning

Turnaround strategies

Our Impact

30+

Years guiding strategy for biopharmaceuticals

200+

Strategy consultants across the United States and Europe

100+

Brands and indications supported annually

10-15

Long-standing client partnerships average 10 to 15 years

Insightful Solutions for Early Innovation

Biotech companies are major contributors to drug discovery, constituting about 60% of the US clinical pipeline and driving growth. But innovation in and of itself is not enough to provide value. Strategic planning is crucial to mitigate risks and demonstrate investment potential to stakeholders.

Learn more

Deep Knowledge Across All Therapeutic Areas

We build practical solutions to maximize portfolio and franchise value. Our scientific, clinical, and business development/licensing experts work across a highly diverse set of therapeutic areas, diving deeply into the dynamics of each individual disease in order to deliver informed recommendations. We approach each challenge with a 360-degree perspective that effectively guides your decision making through meaningful insights and robust strategic thinking.

We have deep and broad experience across all major therapeutic areas. Learn more about our expertise in select key areas:

How we work

Finding Possibilities Where Others See Obstacles

Our People

We pride ourselves on our culture of entrepreneurs who have the drive and creative optimism to turn challenges into triumphs. Blending scientific acumen, consulting approaches, and biopharmaceutical industry experience, our people tackle your toughest questions.

Our Passion

We thrive on taking problems apart and putting them together again as elegant solutions. Our consultants are passionate solvers, doers, and believers.

Our Process

We structure all of our engagements around a Collaborative Process Model, which enables us to build insight and bridge across functions, see new possibilities, and ensure a level of understanding and buy-in that leaves our clients stronger and more knowledgeable at the end of our engagement.

Insatiably Curious and Deeply Committed

Truly tailored solutions and strategies for your most complex life sciences challenges—that is at the heart of what makes us different. We are insatiably curious and deeply committed to challenging the status quo to discover possibilities where others see obstacles. We understand and are inspired by your most intractable challenges and promise to be rigorous, creative, and bold as we help your team navigate the waters ahead.

Explore select specialized solutions and cutting-edge approaches

Innovative Approaches and Solutions

Resource

Portfolio & Brand Strategy: Red Thread Planning™

Webpage

Ignite

Resource

Early TPP360 with Strategy Consulting

Webpage

IEGP

Our Perspectives View all perspectives

Resource

Early TPP360 with Strategy Consulting

Whitepaper Feb 26, 2025

Gene Therapies for Ultra-Rare Diseases: New Partnerships and Business Models

Whitepaper Jan 27, 2025

Oncology Outlook for 2025

Whitepaper Jan 6, 2025

China at the Crossroads in Biopharma Innovation: Exportation or Leadership

Let's Talk

We would love to hear your challenges and discuss how our commercialization strategy experts can help.

Steve Mather Joint Global Practice Lead, Strategy & Insight

Tom Murtagh MBA Joint Global Practice Lead, Strategy & Insight

Jane Ayton Senior Vice President, Strategic Client Partnerships

Jeffrey M. Bockman PhD Expert Advisor, Executive Vice President, Oncology

Zoe Brown Principal, Strategy Consulting

Dennis Chang PhD Senior Vice President, Strategy Consulting

Ellen Edenberg PhD Senior Vice President, Strategy Consulting

Shera Gruen MPH Senior Vice President, Strategy Consulting

Ginger S. Johnson PhD President, BioConsulting, Central Nervous System Co-Lead

Jakub Kaczor PhD, MSc Vice President, Strategy Consulting

Mike Kelly Vice President, Strategy Consulting

David Lomb PhD Vice President, Director of Consulting Services, Autoimmune and Inflammatory Disease Co-Lead

Bart Lombardi MBA Senior Vice President, Strategy Consulting

Danielle Marra MBA, MS Vice President, Strategy Consulting, Autoimmune and Inflammatory Disease Co-Lead

Dominick Mastropoalo MALD Senior Vice President, Strategy Consulting

Bobby Moy MA Senior Vice President, Strategy Consulting

Michael C Rice MS, MBA Expert Advisor, Senior Vice President, Cell and Gene Therapy

Sandy Richardson Principal, Strategy Consulting

Peter Smith Senior Vice President, Strategy Consulting

Petya Spletzer MBA Vice President, Strategy Consulting

Keitel Suri Vice President, Strategy Consulting

Casey Thevenot MPH Principal, Strategy Consulting

Natalie Thovmasian PhD Vice President, Strategy Consulting

Alyssa Trigger MEM Senior Vice President, Strategy Consulting

John Westwood DPhil Senior Vice President, Strategy Consulting

Triona Zelesnik PhD Principal, Strategy Consulting